104 related articles for article (PubMed ID: 38944863)
21. Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.
Garcia-Planella E; Mañosa M; Chaparro M; Beltrán B; Barreiro-de-Acosta M; Gordillo J; Ricart E; Bermejo F; García-Sánchez V; Piqueras M; Llaó J; Gisbert JP; Cabré E; Domènech E;
Scand J Gastroenterol; 2018 Feb; 53(2):152-157. PubMed ID: 29189092
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
Toyonaga T; Kobayashi T; Nakano M; Saito E; Umeda S; Okabayashi S; Ozaki R; Hibi T
PLoS One; 2017; 12(9):e0185131. PubMed ID: 28934315
[TBL] [Abstract][Full Text] [Related]
23. Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial.
Sandborn WJ; Panés J; Zhang H; Yu D; Niezychowski W; Su C
Gastroenterology; 2016 Jan; 150(1):96-102. PubMed ID: 26376350
[TBL] [Abstract][Full Text] [Related]
24. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
[TBL] [Abstract][Full Text] [Related]
25. Bugs and drugs: Predicting response to therapy.
Ananthakrishnan AN
J Gastroenterol Hepatol; 2018 Sep; 33 Suppl 3():27. PubMed ID: 30187562
[No Abstract] [Full Text] [Related]
26. High Perceived Stress is Associated With Increased Risk of Ulcerative Colitis Clinical Flares.
Sauk JS; Ryu HJ; Labus JS; Khandadash A; Ahdoot AI; Lagishetty V; Katzka W; Wang H; Naliboff B; Jacobs JP; Mayer EA
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):741-749.e3. PubMed ID: 35952942
[TBL] [Abstract][Full Text] [Related]
27. Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.
Ferreiro-Iglesias R; Barreiro-de Acosta M; Otero Santiago M; Lorenzo Gonzalez A; Alonso de la Peña C; Benitez Estevez AJ; Dominguez-Muñoz JE
J Clin Gastroenterol; 2016 Feb; 50(2):147-51. PubMed ID: 25811118
[TBL] [Abstract][Full Text] [Related]
28. Rapid Fecal Calprotectin Testing Predicts Mucosal Healing Better than C-reactive Protein and Serum Tumor Necrosis Factor α in Patients with Ulcerative Colitis.
Voiosu T; Benguş A; Bălănescu P; Dinu R; Voiosu A; Băicuş C; Mateescu B
Rom J Intern Med; 2015; 53(3):253-60. PubMed ID: 26710501
[TBL] [Abstract][Full Text] [Related]
29. Ulcerative Colitis in Adults.
Glick LR; Cifu AS; Feld L
JAMA; 2020 Sep; 324(12):1205-1206. PubMed ID: 32857108
[No Abstract] [Full Text] [Related]
30. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin vs. Fecal Immunochemical Test: A Systematic Review and Meta-analysis.
Hu T; Zhang Z; Song F; Zhang W; Yang J
Turk J Gastroenterol; 2023 Sep; 34(9):892-901. PubMed ID: 37427885
[TBL] [Abstract][Full Text] [Related]
32. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients.
Lin WC; Wong JM; Tung CC; Lin CP; Chou JW; Wang HY; Shieh MJ; Chang CH; Liu HH; Wei SC;
World J Gastroenterol; 2015 Dec; 21(48):13566-73. PubMed ID: 26730169
[TBL] [Abstract][Full Text] [Related]
33. Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis.
Krishnakumar C; Ananthakrishnan AN; Boyle BM; Griffiths AM; LeLeiko NS; Mack DR; Markowitz JF; Rosh JR; Sauer CG; Walters TD; Bonkowski E; Denson LA; Hyams JS; Kugathasan S
J Pediatr Gastroenterol Nutr; 2022 Jan; 74(1):72-78. PubMed ID: 34433783
[TBL] [Abstract][Full Text] [Related]
34. Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study.
Bertani L; Blandizzi C; Mumolo MG; Ceccarelli L; Albano E; Tapete G; Baiano Svizzero G; Zanzi F; Coppini F; de Bortoli N; Bellini M; Morganti R; Marchi S; Costa F
Clin Transl Gastroenterol; 2020 May; 11(5):e00174. PubMed ID: 32677804
[TBL] [Abstract][Full Text] [Related]
35. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.
Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI
Gastrointest Endosc; 2017 Dec; 86(6):1070-1078. PubMed ID: 28947363
[TBL] [Abstract][Full Text] [Related]
36. Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis.
Frin AC; Filippi J; Boschetti G; Flourie B; Drai J; Ferrari P; Hebuterne X; Nancey S
Dig Liver Dis; 2017 Jan; 49(1):11-16. PubMed ID: 27693318
[TBL] [Abstract][Full Text] [Related]
37. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
38. [Clinical significance of faecal calprotectin levels in patients with ulcerative colitis].
Hanai H; Tozawa K; Takeuchi K; Iida T; Arai H; Kanaoka S; Sugimoto K; Yoshida K; Iwasaki T; Nakamura A; Hosoda Y; Shirai N; Hirasawa K; Takahira K; Kataoka H; Sano M; Osawa M; Sugimoto S
Nihon Shokakibyo Gakkai Zasshi; 2003 Jan; 100(1):21-7. PubMed ID: 12601924
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: a prospective study.
Jauregui-Amezaga A; López-Cerón M; Aceituno M; Jimeno M; Rodríguez de Miguel C; Pinó-Donnay S; Zabalza M; Sans M; Ricart E; Ordás I; González-Suárez B; Cuatrecasas M; Llach J; Panés J; Pellise M
Inflamm Bowel Dis; 2014 Jul; 20(7):1187-93. PubMed ID: 24874457
[TBL] [Abstract][Full Text] [Related]
40. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.
van Rheenen PF
Inflamm Bowel Dis; 2012 Nov; 18(11):2018-25. PubMed ID: 22275341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
